{"id":43413,"date":"2023-11-07T06:55:13","date_gmt":"2023-11-07T06:55:13","guid":{"rendered":"https:\/\/prosfunds.com\/news\/the-better-than-expected-earnings-plus-cautious-commentary-trend-continues\/"},"modified":"2023-11-07T06:55:16","modified_gmt":"2023-11-07T06:55:16","slug":"the-better-than-expected-earnings-plus-cautious-commentary-trend-continues","status":"publish","type":"post","link":"https:\/\/prosfunds.com\/?p=43413","title":{"rendered":"The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues"},"content":{"rendered":"<div data-test-id=\"content-container\">\n<p><figure class=\"getty-figure\" data-type=\"getty-image\"><picture>  <\/picture><figcaption> <\/figcaption><\/figure>\n<\/p>\n<p>During the second peak week of the Q3 earnings season, the dichotomy between robust Q3 results and cautious Q4 and 2024 outlooks continued to be on display.<\/p>\n<p>Highly anticipated results from Apple (AAPL) came in better<span class=\"paywall-full-content invisible\"> than expected for the most recent quarter, with record iPhone sales, but it was remarks from CFO Luca Maestri that caught investors off-guard.<\/span><\/p>\n<p class=\"paywall-full-content invisible\">Revenue for the company&#8217;s fiscal first quarter is expected to be &#8220;similar&#8221; to FQ1 2023, said Maestri.<sup>1 <\/sup>Investors would likely prefer to see growth, especially in the holiday season. He also warned that revenue for the iPad and Wearables categories would &#8220;decelerate significantly.&#8221;<\/p>\n<p class=\"paywall-full-content invisible\">Investors continued to punish stocks of companies that miss estimates by more than usual, and reward those that surpass estimates by less than usual.<\/p>\n<p class=\"paywall-full-content invisible\">According to FactSet, S&amp;P 500 companies that have surpassed EPS expectations are<span class=\"paywall-full-content no-summary-bullets invisible\"> up 0.8% in the 2 days following the report (vs. the 5-year average of 0.9%), while those missing Wall Street estimates see their stocks plunge by -5.2% on average (vs. the 5-year average of -2.3%).<\/span><sup class=\"paywall-full-content no-summary-bullets invisible\">2<\/sup><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">And while good news on certain Q3 earnings reports has sometimes been bad news for the stock market, on Friday it was bad economic news that translated to good news for stocks as investors digested lower-than-expected Non-farm Payrolls (NFP).<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">The US Labor Department reported NFP rose by 150,000 in October.<sup>3<\/sup> While that was 20,000 fewer than expected, that difference is mostly due to the auto strikes which have since been resolved. Tempered job creation along with flat wage growth makes it less likely that the Federal Reserve will raise rates in the near future.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">With nearly 81% of S&amp;P 500 constituents reporting at this point, the blended EPS growth rate for Q3 has grown to 3.7% vs. last week&#8217;s 2.7%.<sup>4<\/sup><\/p>\n<h2 class=\"paywall-full-content invisible no-summary-bullets\"><strong>Earnings on Deck &#8211; Week of November 6, 2023 <\/strong><\/h2>\n<p class=\"paywall-full-content invisible no-summary-bullets\">This is the third and final peak week of the Q3 earnings season, with expected earnings releases from 3,325 publicly traded companies (out of our universe of 10,000), with 61 of those coming from S&amp;P 500 companies.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Investors will be looking out for results from big names such as Disney (DIS), Uber Technologies (UBER), eBay (EBAY), automobile makers Rivian Automotive (RIVN) and Nio Inc. (NIO) and enterprise tech names: Twilio (TWLO) and HubSpot (HUBS).<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Currently, November 9 is predicted to be the most active day with 1,121 companies anticipated to report. Thus far, 82% of companies have confirmed their earnings date with 45% reporting.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">\n<figure class=\"regular-img-figure paywall-full-content invisible\" contenteditable=\"false\"><picture> <img decoding=\"async\" src=\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/11\/saupload_231016WSHES.png\" alt=\"Q3 earnings season\" contenteditable=\"false\" loading=\"lazy\"> <\/picture><figcaption><\/figcaption><\/figure>\n<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><em>Source: Wall Street Horizon<\/em><\/p>\n<h2 class=\"paywall-full-content invisible no-summary-bullets\"><strong>Potential Surprises This Week: Sleep Number Corp., Vertex Pharmaceuticals<\/strong><\/h2>\n<p class=\"paywall-full-content invisible no-summary-bullets\">This week, we get results from a number of large companies on major indexes that have pushed their Q3 2023 earnings dates outside of their historical norms.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Nine companies within the S&amp;P 500 confirmed outlier earnings dates for this week, all of which are later than usual and therefore have negative DateBreaks Factors*.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Those companies are Celanese Corporation (CE), Vertex Pharmaceuticals Inc. (VRTX), Extra Space Storage (EXR), Waters Corporation (WAT), eBay Inc., Gilead Sciences (GILD), Under Armour (UA), Corteva Inc. (CTVA) and Illumina, Inc. (ILMN) According to academic research<sup>5<\/sup>, the later than usual earnings dates suggest these companies will report &#8220;bad news&#8221; on their upcoming calls.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Also of note, of the nine S&amp;P 500 names with later than usual earnings dates this week, four are from the Health Care sector.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><strong>Sleep Number Corporation (NASDAQ:SNBR)<\/strong><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Company Confirmed Report Date: Tuesday, November 7, AMC<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Projected Report Date (based on historical data): Thursday, November 2, AMCDateBreaks Factor: -3*<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Sleep Number is set to report Q3 2023 results on Tuesday, November 7, five days later than expected. This would be the latest they&#8217;ve ever reported (since we began collecting data for this company in 2018).<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Academic research<sup>6<\/sup> shows when a corporation reports earnings later than they have historically, it typically signals bad news to come on the conference call.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">As consumers become more cost-conscious after a year battling higher inflation, large ticket home items such as mattresses and furniture have been struggling to hit the numbers they did during the post-COVID home improvement boom.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">According to FactSet data, SNBR&#8217;s YoY EPS is expected to decline 18%, while sales are anticipated to fall 5%.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><strong>Vertex Pharmaceuticals (NASDAQ:VRTX)<\/strong><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Company Confirmed Report Date: Monday, November 6, AMC<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Projected Report Date (based on historical data): Thursday, October 26, AMCDateBreaks Factor: -3*<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Vertex Pharmaceuticals is set to report Q3 2023 results on Monday, November 6, eleven days later than expected. This will be the latest they&#8217;ve ever reported third quarter results in our 18 years of history on this name. This will also be their first Monday report.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">VRTX is known for their four Cystic Fibrosis drugs, with its newest CF drug Trikafta\/Kaftrio (in Europe) gaining rapidly in popularity this year. While that will help revenues for Trikafta, analysts worry it will be at the expense of the other drugs in Vertex&#8217;s CF portfolio, possibly causing overall revenues to dip.<sup>7<\/sup><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><em><sup>1<\/sup> \u200bApple Financial Results &#8211; Q4 2023, Apple, November 2, 2023, Apple Earnings Call<\/em><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><em>2 Earnings Insight, FactSet, John Butters, November 3, 2023.<\/em><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><em>3 THE EMPLOYMENT SITUATION \u2014 OCTOBER 2023, U.S. Department of Labor, Bureau of Labor Statistics, November 3, 2023.<\/em><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><em>4 Earnings Insight, FactSet, John Butters, November 3, 2023.<\/em><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><em>5 Time Will Tell: Information in the Timing of Scheduled Earnings News, Journal of Financial and Quantitative Analysis, Eric C. So, Travis L. Johnson, Dec. 2018.<\/em><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><em>6 Time Will Tell: Information in the Timing of Scheduled Earnings News, Journal of Financial and Quantitative Analysis, Eric C. So, Travis L. Johnson, Dec. 2018.<\/em><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><em>7 Vertex (VRTX) to Report Q3 Earnings: What&#8217;s in the Cards?, Barchart, Zacks, October 25, 2023.\u200b<\/em><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">* <em>Wall Street Horizon DateBreaks Factor: statistical measurement of how an earnings date (confirmed or revised) compares to the reporting company&#8217;s 5-year trend for the same quarter. Negative means the earnings date is confirmed to be later than historical average while Positive is earlier.<\/em><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><em>Original Post<\/em><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><strong>Editor&#8217;s Note:<\/strong> The summary bullets for this article were chosen by Seeking Alpha editors.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Editor&#8217;s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.<\/p>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/seekingalpha.com\/article\/4648294-the-better-than-expected-earnings-plus-cautious-commentary-trend-continues?source=feed_all_articles\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>During the second peak week of the Q3 earnings season, the dichotomy between robust Q3 results and cautious Q4 and 2024 outlooks continued to be on display. Highly anticipated results from Apple (AAPL) came in better than expected for the most recent quarter, with record iPhone sales, but it was remarks from CFO Luca Maestri [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":19519,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[38],"tags":[],"class_list":{"0":"post-43413","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues | Prosfunds<\/title>\n<meta name=\"description\" content=\"During the second peak week of the Q3 earnings season, the dichotomy between robust Q3 results and cautious Q4 and 2024 outlooks continued to be on\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prosfunds.com\/?p=43413\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues | Prosfunds\" \/>\n<meta property=\"og:description\" content=\"During the second peak week of the Q3 earnings season, the dichotomy between robust Q3 results and cautious Q4 and 2024 outlooks continued to be on\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prosfunds.com\/?p=43413\" \/>\n<meta property=\"og:site_name\" content=\"Prosfunds\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-07T06:55:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-07T06:55:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/09\/1695970829_image_1463082005.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"969\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/prosfunds.com\/?p=43413#article\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/?p=43413\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\"},\"headline\":\"The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues\",\"datePublished\":\"2023-11-07T06:55:13+00:00\",\"dateModified\":\"2023-11-07T06:55:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/prosfunds.com\/?p=43413\"},\"wordCount\":994,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/prosfunds.com\/?p=43413#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/prosfunds.com\/?p=43413\",\"url\":\"https:\/\/prosfunds.com\/?p=43413\",\"name\":\"The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues | Prosfunds\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/#website\"},\"datePublished\":\"2023-11-07T06:55:13+00:00\",\"dateModified\":\"2023-11-07T06:55:16+00:00\",\"description\":\"During the second peak week of the Q3 earnings season, the dichotomy between robust Q3 results and cautious Q4 and 2024 outlooks continued to be on\",\"breadcrumb\":{\"@id\":\"https:\/\/prosfunds.com\/?p=43413#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/prosfunds.com\/?p=43413\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/prosfunds.com\/?p=43413#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/prosfunds.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/prosfunds.com\/#website\",\"url\":\"https:\/\/prosfunds.com\/\",\"name\":\"Funding Factories\",\"description\":\"Latest Finance News and Updates\",\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/prosfunds.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/prosfunds.com\/#organization\",\"name\":\"Funding Factories\",\"url\":\"https:\/\/prosfunds.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"width\":780,\"height\":140,\"caption\":\"Funding Factories\"},\"image\":{\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/prosfunds.com\"],\"url\":\"https:\/\/prosfunds.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues | Prosfunds","description":"During the second peak week of the Q3 earnings season, the dichotomy between robust Q3 results and cautious Q4 and 2024 outlooks continued to be on","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prosfunds.com\/?p=43413","og_locale":"en_US","og_type":"article","og_title":"The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues | Prosfunds","og_description":"During the second peak week of the Q3 earnings season, the dichotomy between robust Q3 results and cautious Q4 and 2024 outlooks continued to be on","og_url":"https:\/\/prosfunds.com\/?p=43413","og_site_name":"Prosfunds","article_published_time":"2023-11-07T06:55:13+00:00","article_modified_time":"2023-11-07T06:55:16+00:00","og_image":[{"width":1536,"height":969,"url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/09\/1695970829_image_1463082005.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prosfunds.com\/?p=43413#article","isPartOf":{"@id":"https:\/\/prosfunds.com\/?p=43413"},"author":{"name":"News Room","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6"},"headline":"The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues","datePublished":"2023-11-07T06:55:13+00:00","dateModified":"2023-11-07T06:55:16+00:00","mainEntityOfPage":{"@id":"https:\/\/prosfunds.com\/?p=43413"},"wordCount":994,"commentCount":0,"publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/prosfunds.com\/?p=43413#respond"]}]},{"@type":"WebPage","@id":"https:\/\/prosfunds.com\/?p=43413","url":"https:\/\/prosfunds.com\/?p=43413","name":"The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues | Prosfunds","isPartOf":{"@id":"https:\/\/prosfunds.com\/#website"},"datePublished":"2023-11-07T06:55:13+00:00","dateModified":"2023-11-07T06:55:16+00:00","description":"During the second peak week of the Q3 earnings season, the dichotomy between robust Q3 results and cautious Q4 and 2024 outlooks continued to be on","breadcrumb":{"@id":"https:\/\/prosfunds.com\/?p=43413#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prosfunds.com\/?p=43413"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/prosfunds.com\/?p=43413#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/prosfunds.com\/"},{"@type":"ListItem","position":2,"name":"The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues"}]},{"@type":"WebSite","@id":"https:\/\/prosfunds.com\/#website","url":"https:\/\/prosfunds.com\/","name":"Funding Factories","description":"Latest Finance News and Updates","publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prosfunds.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/prosfunds.com\/#organization","name":"Funding Factories","url":"https:\/\/prosfunds.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","width":780,"height":140,"caption":"Funding Factories"},"image":{"@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","caption":"News Room"},"sameAs":["https:\/\/prosfunds.com"],"url":"https:\/\/prosfunds.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/43413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43413"}],"version-history":[{"count":1,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/43413\/revisions"}],"predecessor-version":[{"id":43414,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/43413\/revisions\/43414"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/media\/19519"}],"wp:attachment":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}